期刊文献+

血管紧张素Ⅱ受体拮抗剂对梗死心肌肌腱蛋白分布的影响

Effect of angiotensionⅡ on tenascin-c in infarcted rat heart
下载PDF
导出
摘要 目的探讨血管紧张素Ⅱ(AngⅡ)受体(AT1,AT2)拮抗剂对梗死心肌基质金属蛋白酶(MMPs)及细胞外基质肌腱蛋白(tenascin-c,TN-C)的调节作用。方法结扎大鼠左冠状动脉建立心肌梗死模型,术前7d起分别用安慰剂、AT1受体拮抗剂缬沙坦10mg/(kg.d)、AT2受体拮抗剂PD12331930mg/(kg.d)。术后7d放免法检测左心室游离壁(LVFW)、室间隔(IS)心肌组织基质金属蛋白酶MMP-2,3,9、基质金属蛋白酶组织抑制物-1(TIMP-1)的表达,免疫荧光检测LVFW、IS、RV心肌TN-C的分布。结果与假手术组相比,术后7d手术组、缬沙坦组及PD123319组IS和LVFW的MMP-2,3,9水平显著增加,TIMP-1水平显著减少(P<0.01);TN-C在RV心肌组织及假手术组中不表达,在手术组和PD123319组IS和LVFW中表达增强,缬沙坦组表达较弱。结论AngⅡ参与梗死心肌组织的重构,通过AT1作用于MMPs,调节细胞外基质TN-C等,AT1受体拮抗剂的心脏保护作用与其抑制MMPs及TN-C有关。 AIM To investigate the effect of angiotension Ⅱ ( Ang Ⅱ ) receptors ( AT1. AT2 ) antagonists on matrix metalloproteinases (MMPs) and tenascin-c (TN-C) in infarcted heart of rats. METHODS Rat myocardium infarction (MI) model was established by permanent ligation of the left coronary artery. The infarcted rats were treated respectively with placebo, valsartan (AT1 receptor antagonist, 10 mg/ kg·d) or PD123319 (AT2 receptor antagonist, 30 mg/kg·d), beginning 7days before induction of myocardial infarction. On the 7th day after MI, the levels of MMP-2,3,9, tissue inhibitors of matrix metal-loproteinase-1 (TIMP-1) were determined by radio immunoassay (RIA) in left ventricular free wall (LVFW) and interventricular septum (IS). TN-C distribution was also assayed by immunoflorescence. RESULTS In operation, Valsartan and PD123319 group, the levels of MMP-2,3,9 increased in IS and LVFW, whereas the levels of TIMP-1 decreased, with a significant difference from those in sham group (P 〈0.01 ). There was no expression of TN-C in right cardiac ventricle (RV) and sham groups. TN-C increased in operation and PD123319 groups while decreased in Valsartan group. CONCLUSION Ang Ⅱ is involved in myocardial remodeling in infarcted heart by adjusting MMPs and TN-C via AT1 receptor. The protective effect of AT1 receptor antagonists on the heart may be related to the inhibition of MMPs and TN-C.
出处 《心脏杂志》 CAS 2007年第6期631-634,共4页 Chinese Heart Journal
关键词 心肌梗死 肾素血管紧张素Ⅱ受体 基质金属蛋白酶 肌腱蛋白 myocardial infarction angiotension Ⅱ receptors matrix metalloproteinases tenascin-c
  • 相关文献

参考文献12

  • 1Sandmann S, Yu M, Unger T. Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction-effects of AT1 and AT2 receptor antagonists and ACE inhibitor[ J ]. British Journal of Pharmacology, 2001, 132(3) : 767 -777.
  • 2Wollert KC, Drexler H. The rennin-angiotensin system and experimental heart failure[J]. Cardiov Res, 1999, 43(4):838 -849.
  • 3Roten L, Nemoto S, Simsic J, et al. Effect of gene deletion of the tissue inhibitor of the matrix metallproteinase-type 1 ( TIMP-1 ) on left ventricular geometry and function in mice[ J]. J Mol Cell Cardiol,2000,32( 1 ) :109 - 120.
  • 4Polyakova V, Hein S, Kostin S, et al. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure prog~ssion [ J ]. J Am Coll Cardiol, 2004,44 (8) :1609 -1618.
  • 5Homebeck W, Emonard H, Monboisse JC, et al. Matrix-directed regulation of pericellular proteolysis and tumor progresssion[ J ]. Serain Cancer Biol, 2002,12 (3) : 231 - 241.
  • 6Fedak PW, Verma S, Weisel RD, et al. Cardiac remodeling and failure from molecules to man ( Part II ) [ J ]. Cardiovasc Pathol, 2005,14(2) :49 -60.
  • 7Fedak PW, Smookler DS, Kassiri Z, et al. TIMP-3 deficiency leads to dilated cardiomyopathy [ J ]. Circulation, 2004, 110 ( 16 ) : 2401 - 2409.
  • 8Yi M, Ruoslahti EA. Fibronectin fragments inhibits tumor growth, angiogenesis and metastasis [ J ]. Proc Natl Acad Sci USA, 2001,98 (2) : 620 - 624.
  • 9张军,贾国良,王海昌,郭文怡.大鼠心肌梗死后心肌NF-κB、MMP-2和TIMP-2表达变化及其意义[J].心脏杂志,2006,18(1):54-56. 被引量:8
  • 10Li X, Yang Y, Hu Y, et al. Alphavbeta6-Fyn signaling promotes oral cancer progression [ J ]. The Journal of Biological Chemistry, 2003,278(43) :41646-41653.

二级参考文献42

  • 1Kim HE,Dalai SS,Young E,et al.Disruption of the myocardial extracellular matrix leads to cardiac dysfunction[J].J Clin Invest,2000,106:857.
  • 2Jugdll BI,Kban MI,Jugdull SJ,et al.Effect of prolonged inotropic stimulation on ventricular remodeling during healing after myocardial infarction in the dog:mechanistic insights[J].JACC,1996,27:1787.
  • 3Parodi FE,Mao D,Ennis TL,et al.Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate,an antioxidant inhibitor of nuclear factor-κB[J].J Vasc Surg,2005,41:479 -489.
  • 4Jones WK,Brown M,Ren X,et al.NF-κB as an integrator of diverse signaling pathways:The heart of myocardial signaling[J].Cardiovasc Toxicol,2003,3 (3):229-254.
  • 5Upchurch GR,Welch GN,Fabian AJ,et al.Homocyst(e) inc decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase[J].J Biol Chem,1997,272:17012-17017.
  • 6Mann DL,Spinale FG.Activation of matrix metalloproteinases in the failing human heart:breaking the ties that binds[J].Circulation,1998,97:1699-1702.
  • 7Simoes S,Slepusbkin V,Pretzer E,et al. Transfection of human macrophages by lipoplexes via the combined use of transferrin and PH-sensitive peptides [J].J Leukoc Biol, 1999,65 : 270 - 279.
  • 8Buck AS, Shen C, Schirrmeister H,et al. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis [J]. Cancer Biother Radiopharm, 2002,17(3):281- 289.
  • 9Dasgupta D,Adhya S,Basu MK. The effect of beta-tubulinspecific antisence oligonucleotide encapsulated in different cationic liposomes on the suppression [correction of supression] of intracellular L. donovani parasites in vitro[J]. J Biochem(Tokyo),2002,132(1):23- 27.
  • 10Leonetti C,Biroccio A,Benassi B,et al. Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line[J]. Cancer Gene Ther, 2001,8 (6): 459 - 468.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部